Protocol
The subjects were asked not to consume seafood for 30 days before administration of the chelating agent. They were fasted for 11 h before DMPS and 4 h after DMPS administration.
Urine was collected at -11 to 0 h and at 1, 2, 4, and 9 h after administration of the chelating agent. The dose of 300 mg DMPS was chosen on the basis of previous clinical reports (27). This dose was given to each subject independent of the body weight because the regimen was being developed as a diagnostic test. Urine was collected in acid-washed graduated cylinders having ground glass stoppers.
To the urine immediately after collection, HC1 was added, giving a final concentration of 1%. All glassware was washed with 2% nitric acid. All urine samples were processed in duplicate, at least. Hg was measured as follows: to aliquots (50 ml) of the acidified urine, 20 ml of concentrated nitric acid was added. The samples were digested at 80#{176}C in a water bath for 14 h. The digested urine was brought to a volume of approximately 100 ml by adding 0.1 N HC1, and kept at room temperature for 24 h. The volumes were adjusted to 100.0 ml by the addition of 0.1 N HC1. The urine samples to be examined for mercury content were processed immediately after collection.
Analytical procedures

RESULTS
Clinical
All subjects, except one, had an increase in serum iron level at the 9-h period when compared to baseline. 3) decreased with time at the 0-to 4-h and 0-to 9-h periods but they were still highly significant. One subject developed a macular erythematous rash 1 wk after drug administration.
There was no associated fever, constitutional symptoms, or laboratory abnormalities and the rash resolved spontaneously after 2 days. All three subjects developing side effects were female. All other subjects remained asyptomatic. Nausea and rashes have also been reported after administering DMSA (CHEMET, package insert), a similar chelating agent.
Analytical validation
Validation of the analytical method for determing total urinary mercury was performed as follows. To a freshly voided urine of a normal individual, sufficient mercury nitrate was added to achieve final concentrations of 0.50, 5.0, or 30.0 ng/ml. Two aliquots from each spiked urine sample were put through the digestion procedure and analyzed according to the standardized protocol.
After correcting for the mercury content of the urine before the spike was added, six determinations of the 30.0 ng Hg/mI gave a mean of 28.2 ng Hg/mi (27.2-29.1 ng/ml), six of the 5.0 ng Hg/mI gave a mean of 4.6 ng Hg/ml (4.5-4.7 ng/ml), and six of the 0.5 ng Hg/ml gave a mean of 0.40 ng Hg/ml (0.35-0.46 ng/ml). The major limitation in the analyses of samples at the 0.5 ng/ml level was the small absorption readings obtained on the spectrophotometer.
DISCUSSION
The results of the present experiments show that there is a pool of inorganic mercury in the human body that can be mobilized by administering the chelating agent DMPS and that more mercury is excreted by individuals with amalgams than those without (Table 1 and Fig. 2) . A linear relationship exists between the amalgam score and the urinary mercury after DMPS administration (Fig. 3 ). Those subjects with amalgams had an average urinary mercury excretion before and after DMPS administration of approximately threefold more than that found for those without amalgams (Table 1  and Fig. 2) . Therefore, it appears that two-thirds of the Hg in the urine of students with amalgams originated from mercury vapor that initially had been released from the amalgams in their mouths.
The mercury vapor (Hg#{176}) in the blood and in the brain was then oxidized to mercuric Hg, which was then stored in the tissues. A great deal of the mercuric Hg was deposited finally in the kidneys. It is mercuric Hg that is chelated and excreted in the urine after DMPS treatment, not the Hg#{176} form. Chelation chemistry theory The mercury excretion after DMPS administration has been corrected by subtracting the mercury excretion found for the same length of time before administering DMPS. This was done by collecting the urine for 11 h before DMPS administration and determining the mercury content per 11 h and then calculating the mercury excretion per hour. R coefficient of correlation.
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